Simulation-based power analysis could improve the design of clinical trials in Alzheimer’s disease
View ORCID ProfileDaniel Andrews, View ORCID ProfileDouglas L. Arnold, View ORCID ProfileDanilo Bzdok, View ORCID ProfileSimon Ducharme, View ORCID ProfileHoward Chertkow, View ORCID ProfileD. Louis Collins, the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2022.12.24.22283807
Daniel Andrews
1Department of Biomedical Engineering, McGill University, Montreal, Canada
2McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada
Douglas L. Arnold
2McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada
3Department of Neurology and Neurosurgery, McGill University, Montreal, Canada
4NeuroRx Research, Montreal, Canada
Danilo Bzdok
1Department of Biomedical Engineering, McGill University, Montreal, Canada
2McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada
5Mila – Quebec Artificial Intelligence Institute, Montreal, Canada
Simon Ducharme
2McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada
6Department of Psychiatry, McGill University, Montreal, Canada
7Douglas Mental Health University Institute, McGill University, Montreal, Canada
Howard Chertkow
8Baycrest Centre for Geriatric Care, Toronto, Canada
9Kimel Centre for Brain Health and Wellness and Anne & Allan Bank Centre for Clinical Research Trials, Baycrest, Toronto, Canada
10Canadian Consortium on Neurodegeneration in Aging, Canada
11Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada
D. Louis Collins
1Department of Biomedical Engineering, McGill University, Montreal, Canada
2McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada
3Department of Neurology and Neurosurgery, McGill University, Montreal, Canada
Article usage
Posted December 27, 2022.
Simulation-based power analysis could improve the design of clinical trials in Alzheimer’s disease
Daniel Andrews, Douglas L. Arnold, Danilo Bzdok, Simon Ducharme, Howard Chertkow, D. Louis Collins, the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2022.12.24.22283807; doi: https://doi.org/10.1101/2022.12.24.22283807
Simulation-based power analysis could improve the design of clinical trials in Alzheimer’s disease
Daniel Andrews, Douglas L. Arnold, Danilo Bzdok, Simon Ducharme, Howard Chertkow, D. Louis Collins, the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2022.12.24.22283807; doi: https://doi.org/10.1101/2022.12.24.22283807
Subject Area
Subject Areas
- Addiction Medicine (365)
- Allergy and Immunology (688)
- Anesthesia (184)
- Cardiovascular Medicine (2734)
- Dermatology (234)
- Emergency Medicine (412)
- Epidemiology (12380)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4245)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2743)
- Health Policy (1015)
- Hematology (369)
- HIV/AIDS (875)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4024)
- Nursing (216)
- Nutrition (598)
- Oncology (2117)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (476)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6639)
- Radiology and Imaging (1443)
- Respiratory Medicine (885)
- Rheumatology (420)
- Sports Medicine (350)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)